improvement in AGS compared to glucose-only and BN rat hearts. Infarct size was not different among groups. Even under non-hibernating conditions, AGS hearts performed better after IR than the best-protected rat strain. This, however, appears to strongly depend on metabolic fuel: Intralipid™ led to a significant improvement in return of function in AGS, but not in BN rat hearts, suggesting that year-round endogenous mechanisms are involved in myocardial lipid utilization that contributes to improved cardiac performance, independent of the metabolic rate decrease during hibernation. Comparative lipid analysis revealed four candidates as possible cardioprotective lipid groups. The improved function in Intralipid™-perfused AGS hearts also challenges the current paradigm that increased glucose and decreased lipid metabolism are favorable during myocardial IR. 
Introduction
Coronary artery disease and subsequent myocardial infarction continue to rank among the most common causes of mortality, accounting for nearly 40% of the deaths in the developed world (Gaziano et al. 2010; Roger et al. 2012) and one of every six deaths in the USA (Go et al. 2013 ). Health-care costs in the USA associated with cardiovascular disease exceed $300 billion per year (Go et al. 2013) , in addition to the enormous personal price of severely limited quality of life, loss of productivity and premature death patients experience.
Myocardial ischemia/reperfusion (IR) and their resulting tissue injury are also an unavoidable consequence of cardiac surgery and heart transplantation and remain a major source of perioperative morbidity and mortality (BuenoGonzalez et al. 2010; Ueki et al. 2016) . Prognosis after myocardial IR injury primarily depends on the quantity of irreversibly damaged myocardium (Miller et al. 1995) . Remarkable differences in individual myocardial IR tolerance, however, have been found among (Shen and Vatner 1996) , and even within, different species. For example, the Brown Norway (BN) rat (Rattus norvegicus) exhibits a significantly lower susceptibility to myocardial IR injury than any other rat strain, including Dahl salt-sensitive (SS) rats (Baker et al. 2000) which can be exploited to study some of the phenotypical and genetic determinants of resistance to myocardial IR injury (Shi et al. 2005; Kwitek et al. 2006; Nabbi et al. 2014) .
The physiological phenomenon of hibernation offers another intriguing example of natural adaptation to adverse conditions (Carey et al. 2003) . During hibernation, regulatory mechanisms depress metabolism to as low as 2% of basal rates for days to weeks to support cell preservation and long-term viability in a fasting state (Heldmaier et al. 2004) . Hibernating mammals have also been found to exhibit an extraordinary resistance to IR injury in numerous organs (Lindell et al. 2005; Kurtz et al. 2006; Dave et al. 2006 Dave et al. , 2009 Bogren et al. 2014; Yan et al. 2015) .
A recent in vivo study of deep hypothermic myocardial IR (Quinones et al. 2016 ) compared hibernating and summer-active non-hibernating arctic ground squirrels (Urocitellus parryii, AGS), the hibernating mammal with the lowest body temperature during hibernation (Barnes 1989; Andrews 2007) , as well as the most (BN) and the least IR injury-resistant (SS) rat strain (Baker et al. 2000) . Interestingly, AGS displayed increased resistance against myocardial IR injury even at euthermic body temperatures while under non-hibernating conditions when compared to BN and SS rats; as expected, hibernation further increased this resistance in AGS. A subsequent detailed proteomic analysis suggested that hibernator cardioprotection may be associated with a controlled fuel shift from myocardial carbohydrate to fatty acid metabolism (Quinones et al. 2016) , which is in line with the notion that fatty acids may not just be preferred substrates during hibernation (Galster and Morrison 1975; Yan et al. 2008; Shao et al. 2010 ), but also during true myocardial IR (Quinones et al. 2014) .
In this study, we used Langendorff-perfused isolated hearts from summer-active AGS and BN rats to test the hypotheses that (a) non-hibernating AGS are better protected against normothermic myocardial IR injury than the best-protected rat strain, the BN rat (Baker et al. 2000) ; and (b) that administration of lipids through perfusion with Intralipid™, a Food and Drug Administration-approved lipid emulsion routinely used for total parenteral nutrition (McNiff 1977) , differentially improves resistance against IR injury in AGS more than in BN rat hearts.
Methods

Animals
All investigations conformed to the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research, National Academy of Sciences, 8th edition, 2011) and were approved by the Institutional Animal Care and Use Committees of the Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center (both in Milwaukee, WI, USA). AGS were trapped by licensed members of the Institute of Arctic Biology at the University of Alaska Fairbanks along the Denali Highway in central Alaska in July 2012 and 2013, transported to the University of Alaska Fairbanks for quarantine and testing, and subsequently shipped to the Medical College of Wisconsin. Age-and gender-matched BN rats were obtained from the Department of Physiology at the Medical College of Wisconsin. The BN rat was chosen as it had been identified in several studies to be the rat strain most resistant against myocardial IR injury (Baker et al. 2000; Nabbi et al. 2014) . A total of 11 AGS and 16 BN rats were used during the months of September and October for this study (Table 1) .
Langendorff heart preparation
Animals were anesthetized by inhaled isoflurane (1 to 5 Vol% titrated to loss of consciousness), followed by intraperitoneal injection of 3000 U kg −1 heparin. After a negative response to a noxious stimulus 5 min later, animals were decapitated and hearts were excised through a thoracotomy. The aorta was cannulated distal to the aortic valve, and the heart perfused retrograde with 4 °C cold oxygenated Krebs solution of the following composition (in mM): 148 Na + , 4. .5 glucose, 2 pyruvate, 0.026 ethylene diamine tetraacetic acid, and 5 U/L insulin. The venae cavae were ligated, and the heart was rapidly placed into the support system and perfused at 80 mmHg and 37 °C. The perfusate was equilibrated with 95% O 2 and 5% CO 2 to maintain a constant pH of 7.40 (carbon dioxide partial pressure pCO 2 40 mmHg; oxygen partial pressure pO 2 570 mmHg). The perfusate was filtered (5-µm pore size) in line. Left ventricular pressure (LVP) was measured isovolumetrically with a saline-filled latex balloon (Radnoti LLC, Monrovia, CA) inserted into the left ventricle. Its initial volume was titrated to achieve a diastolic LVP of 10 mmHg at baseline so that any subsequent increase reflected diastolic contracture. LVP-derived data were: systolic, diastolic, and developed (systolic minus diastolic) LVP, and its maximal and minimal first derivatives (dLVP/dt max and dLVP/dt min ) as indices of ventricular contractility and relaxation, respectively. Spontaneous heart rate (HR) was monitored by an electrocardiogram via bipolar electrodes placed in the right atrial and ventricular walls. The rate pressure product (RPP) was calculated as developed LVP • HR to correct for potential HR-induced decreases in developed LVP due to HR-dependent decreases in calcium release from the sarcoplasmic reticulum. Changes in coronary flow, as a result of changes in coronary resistance at a constant perfusion pressure, were measured by an in-line ultrasonic flowmeter (T106X; Transonic Systems, Ithaca, NY, USA).
Experimental protocol
Hearts were randomized to perfusion with either 7.5 mM glucose only or with 7.5 mM glucose plus 1% Intralipid™. Intralipid™ was chosen because it is clinically used and contains a multitude of different lipids including saturated and unsaturated fatty acids (Morris et al. 1998) . Prior experiments in in and ex vivo models of myocardial IR have identified 1% as an optimal concentration to elicit cardioprotection (Rahman et al. 2011; Li et al. 2012) . Hearts from either species were allowed to stabilize for 20 min. Following baseline readings, all hearts were perfused for 5 min with Krebs solution that contained 18 mM K + as cardioplegia; this was necessary to arrest the AGS hearts that would otherwise continue to beat despite subsequent ischemia. Hearts were then subjected to 45 min of global no-flow ischemia before 60 min of reperfusion with continuous monitoring of LVP, heart rate, coronary flow, and nicotinamide adenine dinucleotide (NADH) fluorescence, followed by tissue harvest and ventricular infarct size assessment. If ventricular fibrillation occurred on reperfusion, a bolus of 250 µg lidocaine was immediately injected in the aortic cannula. All data were collected from hearts naturally in, or converted to, sinus rhythm.
Assessment of mitochondrial redox state by spectrophotofluorometry
All experiments were conducted in a light-proof cage to enable continuous measurements of mitochondrial NADH. The distal end of a trifurcated fiberoptic cable (6.8 mm 2 per bundle) was placed gently against the heart's left ventricular anterior wall. A net was applied around the heart to insure optimal contact with the fiberoptic tip. The three proximal ends were connected to a customized spectrophotofluorometer [Photon Technology International (PTI), London, Canada]. Fluorescence was excited with light at the appropriate wavelength from a xenon lamp filtered through a monochromator (Delta RAM; PTI). The beam was focused onto the in-going fibers of the optic bundle, and the shutter was opened only for 3-sec recording intervals at select time points to prevent photo-bleaching. Light at the wavelength used in our studies penetrates transmurally, i.e., all cells from the epicardium to the endocardium contribute to the measured signal (Rhodes et al. 2003) . Emissions were collected by fibers of the other two limbs and filtered before reaching the photomultiplier (PTI). Autofluorescence at 460-nm emission (350-nm excitation) was used to measure changes in mitochondrial NADH (Chance et al. 1965 ) as previously described (Riess et al. Shown are baseline data for the two species, the Brown Norway (BN) rat (n = 16) and arctic ground squirrels (AGS, n = 11). Left ventricular pressure (LVP) in mmHg, spontaneous heart rate (HR) in beats/min, and coronary flow (in ml per min per g heart weight) were measured, and systolic, diastolic, and developed, i.e., systolic-diastolic, LVP, its positive and negative first derivatives dLVP/dt max and dLVP/dt min as indices of contractility and relaxation, respectively, and the rate pressure product (RPP) as the product of developed LVP and HR were calculated at baseline, i.e., after 20-min stabilization. All values are absolute numbers or means ± standard error. 9.3 ± 0.6 6.1 ± 0. . Although autofluorescence may also arise from unknown intracellular constituents or cytosolic NADH, the majority is derived from mitochondrial NADH (Eng et al. 1989) . NADH is given in arbitrary fluorescence units (afu).
Infarct size measurement
At the end of each experiment, hearts were removed, weighed and their atria discarded. Ventricles were cut into 2-mm transverse sections using a heart matrix. Incubation with 1% 2,3,5-triphenyltetrazolium chloride (TTC) in 0.1 M KH 2 PO 4 buffer (pH 7.4, 38 °C) for 10 min (Riess et al. 2009 ) stains viable tissue red by dehydrogenase enzymes present in viable cells, with infarcted areas remaining white. Both sides of each slice were digitally imaged on green background, and their infarcted areas measured automatically by planimetry using Image J 1.44i software (NIH, Bethesda, MD), its ColorThreshold plugin and a custom-developed, calibrated macro ensuring fast and operator-independent measurements (Shidham et al. 2011) . Infarcted areas were averaged on the basis of their weight to calculate the total ventricular infarction of each heart.
Lipid analysis
Blood samples were collected from all animals immediately after decapitation and centrifuged at 500g for 10 min at 4 °C. The plasma supernatant was aspirated and immediately frozen at −80 °C. Plasma samples from AGS and rats as well as 1% Intralipid™ were subsequently analyzed for their lipid composition. Over 1800 lipid measurements by mass spectrometry produced a profile of 399 lipids. ESI-MS/MS lipid profiling of phospholipids and cholesterol esters was performed as described by Zhou and colleagues (Zhou et al. 2012) ; triacylglycerol analysis, resulting in 44 triacylglycerol species, was performed as described by Li and colleagues (Li et al. 2014 ).
Statistical analysis
All analog signals were digitized (PowerLab/16 SP, ADInstruments North America, Colorado Springs, CO) and recorded at 200 Hz (Labchart, ADInstruments) for later analysis. All data are expressed as the mean ± standard error of the mean. Composite baseline data were compared by one-way analysis of variance (SigmaStat 3.5, Systat Software Inc, San Jose, CA, USA), and all other data were compared by two-way analysis of variance with species and substrate as two independent factors. If F values were significant, Student-Newman-Keuls post hoc tests were conducted. Tests were considered statistically significant at P < 0.05 (2-tailed): *vs glucose only, † vs BN.
Results
Baseline data
AGS were significantly heavier than their BN counterparts as were their respective hearts (Table 1 ). The ratios of heart weight to body weight, however, were not different between the species or treatment groups. Baseline coronary flow per g heart weight was higher in BN rat than in AGS hearts; all other baseline functional data were not different between the species or treatment groups.
Myocardial and coronary function
There was no significant effect of species or treatment on the incidence of ventricular fibrillation upon reperfusion. Systolic LVP, expressed as % baseline, upon reperfusion (Fig. 1a) was the lowest in the BN glucose group and not different to the BN intralipid group. The AGS glucose group had a higher systolic LVP than the two BN groups. The AGS intralipid group exhibited an even higher systolic LVP than the other three groups throughout reperfusion. Diastolic contracture, expressed in mmHg (panel b), occurred in all hearts, starting during ischemia and lasting throughout reperfusion. While there was no difference among BN glucose, BN intralipid and AGS glucose hearts, AGS intralipid hearts exhibited a significantly later increase in diastolic LVP during ischemia, and a significantly lower contracture both during ischemia as well as throughout reperfusion compared to all other groups.
All of the above contributed to better developed LVP (panel c), contractility (dLVP/dt max , panel d) and relaxation (dLVP/dt min , not shown), as well as a better RPP (panel e) for the AGS intralipid group than the other three groups. Developed LVP and contractility were also higher in the AGS glucose group compared to the two BN groups, RPP was not. Coronary flow (panel f) returned at a significantly Fig. 1 shows the time courses of a systolic (in % baseline, bl), b diastolic (in mmHg), and c developed (systolic-diastolic, in % bl) left ventricular pressure (LVP), d dLVP/dt max (in % bl), e the rate pressure product (RPP, in % bl), f coronary flow (CF, in % bl), and g NADH autofluorescence (in arbitrary fluorescence units, afu) before, during, and 45 min of global no-flow in hearts isolated from Brown Norway (BN) rats (blue triangles) compared with hearts isolated from arctic ground squirrels (AGS, red circles) perfused with either 7.5 mM glucose only (closed symbols, continuous lines) or 7.5 mM glucose and 1% Intralipid™ (open symbols, interrupted lines) . h ventricular infarct size (in %) for each of the four groups. CP: perfusion with cardioplegia for 5 min before ischemia. Dotted and interrupted straight lines in g represent average change in NADH fluorescence from 10 to 45 min of ischemia. Statistical symbols for P < 0.05 are asterisk vs glucose only, and dagger vs BN ◂ higher rate in Intralipid™-treated AGS hearts than in glucose-only AGS or BN hearts; Intralipid™ did not affect coronary flow in BN hearts.
Mitochondrial redox state
With the onset of global ischemia, all hearts exhibited the previously described (Riess et al. 2002a (Riess et al. , 2004 pattern of initially increased mitochondrial reduction (increased NADH fluorescence, panel g) with the AGS glucose group exhibiting a significantly higher initial reduction than the other three groups. This was followed by an abrupt oxidation, i.e., return toward or below baseline levels upon reperfusion. While there was no difference in mitochondrial redox state among the other three groups, BN hearts treated with glucose only exhibited a profound and sustained oxidation throughout the entire reperfusion period. During ischemia, the AGS intralipid group did not exhibit the same continuous rate of oxidation (decrease in NADH) (Riess et al. 2002a (Riess et al. , 2004 as the other three groups.
Ventricular infarct size
There were no significant differences among the four groups comparing ventricular infarct size as assessed by TTC staining (panel h).
Gender
We did not find a significant effect of gender in either of the species on any of the tested parameters.
Lipid analysis
Comparisons between BN, AGS, and Intralipid™ revealed four different lipid groups that were commonly higher in 1% Intralipid™ and in AGS plasma compared to BN rat plasma (Table 2) : (1) phosphatidyl-choline by 4.5-and 1.5-fold; (2) lyso-phosphatidyl-ethanolamine by 17.0-and 2.1-fold; (3) phosphatidyl-ethanolamine by 136.9-and 8.4-fold;
and (4) ether-linked phosphatidyl-ethanolamine by 28.7-and 2.3-fold in 1% Intralipid™ and AGS plasma, respectively, compared to BN rat plasma.
Discussion
This study, for the first time, characterizes and compares the effects of normothermic myocardial IR in hearts isolated from summer-active AGS with those from the bestprotected rat strain, the BN rat, and reports a differential effect of Intralipid™ on cardiac function after cardioplegic IR in both species. Our comparative analysis revealed a significantly improved systolic function under glucose-only conditions in AGS compared to BN rats. The additional administration of Intralipid™ as a source for lipids dramatically improved not only systolic, but also diastolic function both during ischemia and throughout reperfusion, as well as coronary flow during reperfusion, and mitochondrial redox state during ischemia in AGS, but not in BN rats. Mitochondrial NADH autofluorescence was significantly lower initially during ischemia in the AGS intralipid compared to AGS glucose hearts, possibly as a consequence of less glucose utilization and increased β-oxidation. More importantly, and as consistently observed with other cardioprotective strategies (Riess et al. 2002a (Riess et al. , 2004 , redox state became more oxidized during reperfusion in BN rats treated with glucose only, while there was no difference between BN rats treated with Intralipid™ and either AGS group. In contrast, TTC-based infarct size analysis did not show significant differences between species or treatments. A comprehensive lipid analysis identified four major lipid groups to be more prevalent in both AGS plasma and in 1% Intralipid™ versus BN rat plasma.
Mammalian hibernation is a powerful physiological mechanism to drastically reduce energy expenditure seasonally by reducing metabolism at times of reduced to completely ceased food supply. It is characterized by phases of torpor lasting for days to weeks that go along with reduced physical activity, decreased metabolism and body temperature (Andrews 2007; Sheriff et al. 2011 ). These are Table 2 Comparisons of significantly different lipid groups from 1% Intralipid™ and AGS plasma vs BN rat plasma Shown are the four lipid groups found to be significantly higher in both 1% Intralipid™ and in plasma from arctic ground squirrels (AGS) compared to plasma from Brown Norway (BN interrupted by short episodes of interbout arousals during which metabolism and temperature return to normal for several hours (Andrews 2007; Karpovich et al. 2009 ). While going in and out of torpor with concomitant manifold changes in metabolism and hemodynamics may constitute repeated global IR injury by itself, organs of hibernating mammals are also protected against true IR injury as shown in models of global ischemia during cardiac arrest (Dave et al. 2006 (Dave et al. , 2009 Bogren et al. 2014) , as well as liver (Lindell et al. 2005) , intestinal (Kurtz et al. 2006) , and most recently myocardial IR (Heinis et al. 2015; Quinones et al. 2016) . Little is known, however, about year-long endogenous organ protective mechanisms in hibernating mammals that may persist during non-hibernating euthermic conditions and are independent of hibernation-induced reductions in metabolism and temperature (Dave et al. 2006 ). Quinones et al. (Quinones et al. 2016 ) have used a technically demanding in vivo model of deep hypothermic cardioplegic cardiac arrest, adapted from the rat (de Lange et al. 2008 ) to the AGS, and compared myocardial IR injury patterns between non-hibernating rodents (BN and SS rats) and AGS that were summer-active and those that hibernated. In their model, the phenotype of cardioprotection in summer-active AGS was found to be intermediate between the best IR-protected (BN) rat and hibernating AGS.
The goal of the present study was to investigate if, and how, cardioprotection against IR injury can be further enhanced even under non-hibernating and normothermic conditions. Summer-active AGS exhibit a similar temperature, metabolism, hemodynamic patterns, and behavior as rats, so that neither of the above would be associated with or identified as a cause for any observed differences in outcome. However, hearts from summer-active AGS displayed an already improved return of function compared to the best-protected rat under standard glucose-only conditions. When mimicking their naturally occurring hyperlipidemia (Galster and Morrison 1975) by addition of 1% Intralipid™ to the perfusate, AGS-isolated hearts performed even better following myocardial IR, clearly suggesting a differential capacity and preference for fatty acid metabolism in AGS even under non-hibernating conditions compared to the rat. Thus, the presence of lipids to be metabolized may be necessary but by far not sufficient by itself for cardioprotection without a concomitant fuel switch present in the hibernator vs the non-hibernator heart.
In contrast to the studies by Rahman et al. (Rahman et al. 2011) and Li et al. (Li et al. 2012 ), we did not give Intralipid™ as a 'postconditioning' agent only upon reperfusion, but rather before and after ischemia to mimic the AGS hearts' natural hyperlipidemic environment. The 'preconditioning' effect of the Intralipid™ in the AGS hearts was clearly evidenced by the absent mitochondrial oxidation and the much delayed and attenuated diastolic contracture during late ischemia. Both are typically a result of better intracellular calcium handling and less calcium overload during ischemia and on reperfusion (Riess et al. 2002b (Riess et al. , 2004 , a phenomenon also reported in hibernating 13-line ground squirrels (Heinis et al. 2015) . Also in contrast to Rahman et al. (Rahman et al. 2011 ), we did not see additional improvement in any of the functional indices, including RPP, with the administration of 1% Intralipid™ in the rat; this may be due to the maximal endogenous protection in the BN vs all other rat strains (Baker et al. 2000) that cannot be further improved by conditioning ) and has been reported to be nitric oxidedependent (Shi et al. 2005; Stowe et al. 2012) . In fact, we recently reported nitric oxide release from endothelial cells as a possible mechanism of cardioprotection by Intralipid™ (Douglas et al. 2016) .
Our cross-comparison of lipid levels between 1% Intralipid™, AGS, and BN rat plasma revealed a multitude of individual lipids whose respective concentrations were significantly and multifold higher or lower among the three tested groups. When narrowing them down from individual lipids to chemically related lipid groups and searching for common differences between 1% Intralipid™ and plasma from AGS (both associated with improved function after IR) on one and BN rat plasma on the other side, we identified (1) phosphatidyl-choline; (2) lyso-phosphatidyl-ethanolamine; (3) phosphatidyl-ethanolamine; and (4) etherlinked phosphatidyl-ethanolamine to be highly significantly increased in 1% Intralipid™ and AGS plasma, respectively, compared to BN rat plasma and, therefore, as possible candidates to convey improved myocardial function after IR in our model. Clearly, more research on their significance and possible individual effects in non-hibernators will have to be conducted. Nevertheless, our finding of enhanced post-IR performance by Intralipid™ in hibernators challenges the current paradigm of increased glucose utilization and inhibition of lipid metabolism as always favorable during myocardial IR (Lopaschuk et al. 1988; Quinones et al. 2014) .
Adding to the uncertainty about possible mechanisms of Intralipid™-mediated cardioprotection is contradictory report about the role of fatty acids during the different phases of IR. While an earlier study in rabbit isolated hearts could show a protective role for Intralipid™ only on reperfusion ( Van de Velde et al. 2000) , a later study in rat isolated hearts reported a benefit when given as a pre-or as a postconditioning agent (Liu et al. 2008 ). The latter is in line with the present findings in Langendorff-prepared hearts from AGS where 1% Intralipid™ clearly improved post-IR function when given before and after IR. The role of glucose vs fatty acid metabolization in attenuating IR injury has indeed been the subject of a number of investigations and reviews (Jani and Bergmann 2006; Barsotti et al. 2009; Jaswal et al. 2011 ). On one side, it is entirely conceivable that fatty acids can serve as a more efficient fuel during myocardial IR (Jaswal et al. 2011) . On the other hand, metabolic modulators shifting metabolism preferentially to glucose utilization are a newer class of drugs to ameliorate myocardial IR injury (Jani and Bergmann 2006) . Inhibition of fatty acid oxidation by etomoxir, for example, has been shown to be highly cardioprotective (Lopaschuk et al. 1988) .
Several limitations to our study need to be acknowledged. Due to the current inability to breed AGS in captivity, they have to be trapped in the wild, which limits their availability to us for research, and therefore, their respective research group sizes. Thus, the study was not designed or powered to exclude a type 2 error in further subgroup analyses. This research project did not include hearts from hibernating AGS or other hibernating mammals which may have added further important findings to this study. Instead of studying the specific effects of individual lipids, we used Intralipid™, a water soluble fat emulsion approved for human use as a part of total parenteral nutrition (McNiff 1977) , made of soy bean oil, egg phospholipids and glycerin and consisting of a multitude of different lipids (Morris et al. 1998) . The fact that only functional parameters were found to be improved in AGS with and without Intralipid™, but not infarct size, points more toward improved stunning rather than reduced infarction following myocardial IR. Furthermore, we cannot exclude with certainty that our findings were not influenced, in part, by a possible species-or strain-dependent differential preconditioning effect Shi et al. 2005; Stowe et al. 2012 ), e.g., by exposure to a volatile anesthetic in vivo before the isolation of the heart. This, however, would not be expected to affect our intralipid-related findings. Finally, we used an isolated heart model with a blood-and plasmafree perfusate, devoid of autonomic and hormonal input, all of which may have influenced our findings.
In summary, even under non-hibernating euthermic conditions, AGS hearts are better protected against stunning following IR than the best-protected rat strain. Furthermore, Intralipid™ perfusion leads to a remarkable improvement in return of function in AGS, but not in BN rats, suggesting that year-round endogenous mechanisms involved in myocardial lipid utilization without the production of harmful metabolites contribute to improved outcome, independent of decreased metabolism during hibernation. The concept of metabolic fuel switching in the AGS heart, with increased fatty acid oxidation, challenges the current paradigm that increased glucose and decreased lipid metabolism are always favorable during myocardial IR.
